论文部分内容阅读
目的观察痰热清与阿奇霉素治疗急性上呼吸道感染的疗效。方法将326例急性上呼吸道感染患者,分为痰热清组89例,用痰热清注射液20ml静滴,1次/d;阿奇霉素组237例,用阿奇霉素针0.5g静滴,1次/d。二组常规给予对症、支持治疗。比较二组不良反应发生率、疗效、用药时间。结果二组不良反应发生率:痰热清组3.4%(3/89),阿奇霉素组18.2%(43/237),比较差异有统计学意义(P<0.01);二组疗效:体温恢复正常的时间、上呼吸道症状缓解时间、用药天数,比较差异无统计学意义(P>0.05)。结论痰热清治疗急性上呼吸道感染,疗效确切,不仅不良反应发生率低,而且还减少抗生素的使用,相应减少了抗生素耐药的发生。
Objective To observe the effect of Tanreqing and azithromycin in the treatment of acute upper respiratory tract infection. Methods A total of 326 patients with acute upper respiratory tract infection were divided into Tanreqing group (n = 89), Tanreqing injection (20ml) once daily, azithromycin group (237 cases) d. Two groups routinely symptomatic, supportive treatment. The incidence of adverse reactions, efficacy and medication time in the two groups were compared. Results The incidence of adverse reactions in the two groups was 3.4% (3/89) in Tanreqing Group and 18.2% (43/237) in Azithromycin group, with significant difference (P <0.01). The curative effect of the two groups was normal Time, upper respiratory tract remission time, medication days, the difference was not statistically significant (P> 0.05). Conclusion Tanreqing treatment of acute upper respiratory tract infection, the exact effect, not only the incidence of adverse reactions is low, but also reduce the use of antibiotics, a corresponding decrease in the occurrence of antibiotic resistance.